Much like its new space in Rochester, MN, Nucleus RadioPharma is coming to Lower Gwynedd Township. (Image courtesy of Nucleus RadioPharma)
Nucleus RadioPharma, a contractor for AstraZeneca, aims to build in Spring House
With its newest offices planned for Lower Gwynedd, 50 new jobs are coming to the township. The international pharmaceutical company, Nucleus RadioPharma, based in Minnesota, has announced its growth has opportunity headed to the Wissahickon communities.
The firm, which is an AstraZeneca-backed division, said it will build its new 48,000-square-foot in Lower Gwynedd Township thanks to its proximity to the Fox Chase Cancer Center. With its facility slated for the 700 block of Norristown Road, it will be just over 10 miles to Philadelphia’s Cottman Avenue location, 10 miles from the Rockledge, Huntingdon Pike offices, and 10.2 miles from the East Norriton offering on DeKalb Pike.
“The new facility will enable faster access to life-saving treatments for patients with limited therapeutic options, while also bringing significant economic growth to the region,” said Fox Chase Cancer Center CEO Robert Uzzo. “The availability of high-quality manufacturing space is crucial for accelerating clinical trials and ultimately improving outcomes for patients battling cancer.”
Spring House Innovation Park, north of the city, is “strategically positioned to serve key markets,” said the company’s release.
According to the release, the expansion will bring 50 new jobs to the area in the industry of radiopharmaceuticals. Nucleus RadioPharma is focusing its efforts on contract development and manufacturing organization. The expansion hopes to “contribute to local economic growth and strengthening these regions as hubs for healthcare innovation.”
In addition to the Lower Gwynedd Township space, the company is also adding one to Mesa, Ariz.
“We’re excited to welcome Nucleus RadioPharma's new facility to Mesa," said Mesa’s Mayor John Giles. "Their investment brings dozens of well-paying jobs to our city, boosting our local economy and enhancing our reputation as a hub for innovation. This expansion opens new doors for our local workforce and underscores Mesa's role in supporting cutting-edge technology development. I'm confident this partnership will have long-lasting benefits for our community as well as patients across the nation."
